NCT06920368 Different Techniques for Prevention of Complications After Septoplasty Operation
| NCT ID | NCT06920368 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Septoplasty |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-05-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the aim of the study is to compare complication of trans-nasal quilting sutures, nasal pack and intra intranasal silicon splint in endoscopic septoplasty
Eligibility Criteria
Inclusion Criteria: * Healthy adult patient of different ages from 16 to 60 year-old with symptomatic deviated nasal septum Exclusion Criteria: * Patient with nasal polyposis or nasal tumors or patients with sinusitis not responding to medical treatment. * Patient with previous septal operation * Patient who is planned to do partial inferior turbinectomy or turbinoplasty with septoplasty * Patients with contraindications for general surgery
Contact & Investigator
Emad Mohamed Shehata, Professor
PRINCIPAL INVESTIGATOR
Tanta University Hospitals
Frequently Asked Questions
Who can join the NCT06920368 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 60 Years, studying Septoplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06920368 currently recruiting?
Yes, NCT06920368 is actively recruiting participants. Contact the research team at ahmed179467_pg@med.tanta.edu.eg for enrollment information.
Where is the NCT06920368 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06920368 clinical trial?
NCT06920368 is sponsored by Tanta University. The principal investigator is Emad Mohamed Shehata, Professor at Tanta University Hospitals. The trial plans to enroll 90 participants.